Related Experiment Video
Updated: Jun 12, 2025
07:05
Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
Published on: January 3, 2017
8.9K
2024 FDA-approved psychotropic medications: A conspectus
Ahmed Naguy1, Nadyah Alayadhi2, Ali Al-Tajali3
1Child/Adolescent Psychiatrist, Al-Manara CAP Centre, Kuwait Centre for Mental Health (KCMH), Jamal Abdul-Nassir St, Shuwaikh, State of Kuwait.
Asian Journal of Psychiatry
|September 20, 2024
Summary
The US FDA approved new psychotropic drugs in August 2024, offering innovative treatments for various mental health conditions. This update provides essential information for clinicians on recent advancements in psychopharmacotherapy.
Area of Science:
- Psychopharmacology
- Neuroscience
- Clinical Psychiatry
Background:
- Review of recent US FDA-approved psychotropic medications as of August 2024.
- Focus on drugs offering novel mechanisms or improved efficacy in psychopharmacotherapy.
- Aimed at providing a concise update for busy clinicians.
Discussion:
- Highlighting the potential impact of newly approved agents on treatment paradigms.
- Comparing new approvals with existing therapeutic options.
- Addressing potential challenges and considerations for clinical implementation.
Key Insights:
- Several novel psychotropic agents have received FDA approval, expanding therapeutic options.
- These approvals represent potential advancements in managing psychiatric disorders.
- Clinicians should be aware of these new pharmacological tools.
Outlook:
- Anticipated integration of these new drugs into clinical practice.
- Future research directions and post-market surveillance needs.
- Potential for improved patient outcomes through enhanced psychopharmacotherapy.
Related Concept Videos
01:28Psychosis and Antipsychotic Drugs: Overview
192
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
192
01:23Antidepressant Drugs: MAOIs and Other Agents
201
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
201
01:28Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
01:25Antidepressant Drugs: Overview
377
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
377
01:26Psychosis: Goals of Pharmacotherapy
110
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
110
01:21Antipsychotic Drugs: Typical and Atypical Agents
160
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
160